Soc. Generale Knock-Out MRK 21.06.../ DE000SU630V5 /
2024-05-21 2:30:50 PM | Chg.+0.410 | Bid3:07:11 PM | Ask3:07:11 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.490EUR | +10.05% | 4.360 Bid Size: 5,000 |
4.560 Ask Size: 5,000 |
MERCK KGAA O.N. | - EUR | 2024-06-21 | Call |
GlobeNewswire
1:00 PM
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA